Elevation Oncology, Inc. - COM (ELEV)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
45.9M
Holdings value Q3 2024
$27.6M
Value change Q3 2024
-$42.3M
Grand Portfolio weight change Q3 2024
0%
Number of holders
67
Number of buys Q3 2024
36
Number of sells Q3 2024
-45
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 45.9M $27.6M -$42.3M $0.60 68
2024 Q2 52.1M $140M +$17.1M $2.70 79
2024 Q1 44M $226M +$110M $5.13 61
2023 Q4 25.8M $13.9M -$1.44M $0.54 31
2023 Q3 28M $18.6M -$5.58M $0.66 40
2023 Q2 31.5M $48.8M +$23M $1.52 38
2023 Q1 16.2M $30.8M +$3.71M $1.90 26
2022 Q4 14.4M $13.7M +$91.7K $0.95 26
2022 Q3 14.3M $16.1M -$1.53M $1.13 21
2022 Q2 15.4M $21.5M -$7.04M $1.40 24
2022 Q1 18.7M $47.2M +$632K $2.52 28
2021 Q4 15.9M $95.9M -$3.12M $6.02 33
2021 Q3 15.9M $123M -$8.55M $7.79 21
2021 Q2 16.2M $217M +$217M $13.57 35